Sahpra News Updates

Pretoria, 27 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) is pleased to announce the registration of Lenacapavir. Lenacapavir is an antiviral medicine that is recommended, in combination with safer sex practices, for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection in adults... The post  SAHPRA Registers Lenacapavir… Read more »

Picture a young girl watching her parents navigate the daily maze of diabetes management- checking blood glucose levels, calculating insulin doses, searching for affordable medications, and hoping that tomorrow’s treatment will be accessible. In that quiet observation lies the seed of a revolution, the birth... The post Khanyisile Nkuku: Revolutionizing… Read more »

Pretoria, 15 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) and the Health Professions Council of South Africa (HPCSA) signed a Memorandum of Agreement (MOA) on 18 August 2025 for five years. The main objective of this MOA is to enable collaboration... The post  SAHPRA and HPCSA… Read more »

Pretoria, 28 September 2025 – The South African Health Products Regulatory Authority (SAHPRA) wishes to reassure the public that paracetamol remains a safe and recommended option for the relief of pain and fever during pregnancy, when used short-term at recommended doses. Paracetamol is one of... The post SAHPRA clarifies that… Read more »

Dear Stakeholders, Please be advised that the SAHPRA Pretoria Office is currently operating remotely. For any enquiries, we kindly request that you email or call the relevant unit directly. Our teams remain fully available to assist you during this period. Access our Key Contacts here.... The post SAHPRA Pretoria Office… Read more »

Pretoria, 27 August 2025 –The South African Health Products Regulatory Authority (SAHPRA) has approved a molecular test kit for Mpox , Cobas MPXV, for use on the Cobas 6800/8800 Systems, within nine working days through a collaborative and harmonised review process under the African Medicines Regulatory Harmonisation (AMRH). Rapid... The post SAHPRA Approves Mpox… Read more »

Pretoria, 21 August 2025 – The South African Health Products Regulatory Authority (SAHPRA) is proud to announce that it has obtained a clean audit outcome from the Auditor-General of South Africa (AGSA) for the 2024/2025 financial year, following its first clean audit for the 2023/24... The post SAHPRA attains clean… Read more »

Pretoria, 15 July 2025 – The South African Health Products Regulatory Authority (SAHPRA) was notified of the Lancet Global Health 2025; 13: e1250, an investigational study and its findings on substandard anti-cancer medications in Sub-Saharan African countries, including Ethiopia, Kenya, Malawi, and Cameroon. This study... The post  SAHPRA‘s position on… Read more »

Pretoria, 02 July 2025 – The South African Health Products Regulatory Authority (SAHPRA) welcomes its newly appointed Board Members. The SAHPRA Board is appointed by the Minister of the National Department of Health, Dr Aaron Motsoaledi. The appointment is in accordance with section 2C(2) of... The post  SAHPRA welcomes new… Read more »

Pretoria, 18 June 2025 Meeting highlights: EF: What are you most proud of in your five-year tenure leading SAHPRA, and what do you consider the key highlights of this period?  BS: We did a lot, but I would say it falls into three main areas, considering where SAHPRA... The post Executive Forecast 2025:… Read more »